Clinical Trials Directory

Trials / Sponsors / Biocity Biopharmaceutics Co., Ltd.

Biocity Biopharmaceutics Co., Ltd.

Industry · 11 registered clinical trials — 5 currently recruiting.

StatusTrialPhaseStarted
Not Yet RecruitingBC3195 in Combination With Pembrolizumab in Participants With Locally Advanced or Metastatic Solid Tumors
Locally Advanced or Metastatic Solid Tumors
Phase 1 / Phase 22026-03-17
RecruitingA Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Preliminary Efficacy of BC2027 in Pat
Advanced Solid Malignancies
Phase 12025-11-24
RecruitingA Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria
IgA Nephropathy (IgAN)
Phase 32025-02-14
RecruitingA Study to Assess the Safety, Pharmacokinetics, and Antitumor Activity of BC3195 in Patients With Advanced or
Advanced Cancer, Metastatic Solid Tumor
Phase 12024-06-24
UnknownSC0191 Plus Chemotherapy in Advanced Ovarian Canceradvanced Ovarian Cancer
Serous Ovarian Cancer, Advanced Ovarian Cancer
Phase 1 / Phase 22023-10-30
Not Yet RecruitingBC3402 in Combination With Durvalumab in Patients With Advanced Hepatocellular Carcinoma
Hepatocellular Carcinoma
Phase 1 / Phase 22023-10-01
UnknownA Phase I Study of BC3402 as a Single Agent in Patients With MDS and CMML
Hematologic Malignancy
Phase 12023-07-06
UnknownStudy of BC3195 Monotherapy in Patients With Advanced Solid Tumors
Locally Advanced or Metastatic Solid Tumors
Phase 12023-06-26
UnknownStudy of BC3402 in Combination With Azacitidine in Patients With MDS and CMML
Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia
Phase 12023-06-18
Active Not RecruitingA Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease
Diabetic Kidney Disease, IgA Nephropathy
Phase 22023-05-23
UnknownSC0245 and Irinotecan in Treating Patients With Relapsed Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
Small Cell Lung Cancer
Phase 1 / Phase 22023-02-23